Genmab — Oktober 2017
-
Solsen - 5 års behandling dara/rev/dex vil da være meget dyrere end 1 gang car-t!
-
on CAR-T , Novartis requested FDA approval for Kymriah for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) http://in.reuters.com/article/us-novartis-kymriah/novartis-asks-fda-to-expand-kymriahs-use-against-blood-cancer-idINKBN1D00QR?feedType=RSS&feedName=health&utm_source=Twitter&utm_medium=Social&utm_campaign=Feed%3A+reuters%2FINhealth+(News+%2F+IN+%2F+Health)
-
EL - I wanted to be conservative

-
Solsen - jeg synes ellers konsensus her på chatten er en 5 års PFS på Pollux
-
Ikke som det er nu Bulder. Men som Sukkeralf skrev i går, så kan der vel ske en udvikling af car-t, så den bliver mere sikker.
-
jeg synes bare det er farligt at feje al mulig konkurrence under bordet.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
